Medicare Rx Premium Beats Projections Due To “Robust Competition”
Executive Summary
The Centers for Medicare & Medicaid Services is playing up Part D premium levels as a sign that healthy competition among drug plans will help the program suit the pocketbooks of both beneficiaries and the federal government